An Evidence-Based Approach to Covid-19 Vaccination
May 7, 2026DOI: 10.1056/nejmc2507760CorrespondenceNEJM
[Free Article]To the Editor: In their Sounding Board article (June 26 issue), Prasad and Makary ignore the fact that the risks of SARS-CoV-2 infection extend beyond acute outcomes such as hospitalization and death. Long Covid can affect anyone, regardless of disease severity and coexisting conditions; according to the latest data from the National Center for Health Statistics, an estimated 1.6 to 1.8% of all U.S. persons 40 to 59 years of age show substantial activity limitations due to the manifestations of long Covid. Furthermore, in the months after infection, SARS-CoV-2 infections have been shown to increase predisposition for cardiovascular disease, regardless . . .